Travelan

Drug identity checked against registry records

Also recorded as IMM-124E

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.NCT05933525IMRNPhase 2Completed2024-07-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.